论文部分内容阅读
由中国抗癌协会肿瘤生物治疗专业研究会、中国免疫学会肿瘤免疫与生物治疗专业委员会和中华医学会肿瘤学会联合主办的“第五届全国肿瘤生物治疗会议”于1997年9月21日至25日在四川成都隆重召开.这次会议是国内迄今规模最大的肿瘤生物治疗学术会议,来自国内27个省、市、自治区200多家医疗研究单位的代表和日本、美国、台湾地区的学者及卫生部有关领导共300余人参加了会议.国内知名专家学者张友会、董志伟、顾健人、钱振超、曹雪涛、汤健、田志刚、马大龙、王琰、魏于全、寿成超等在大全上作特邀报告,主要讲题包括:一种治疗肿瘤肺转移的新途径、我国肿瘤发病趋势及生物技术在其防治中的意义、基因治疗的昨天今天和明天、肿瘤主动特异性免疫治疗的进展、抗原提呈细胞与肿瘤生物治疗、非病毒介导的基因转移、NK细胞与免疫学调节功能、细胞因子研究进展、基因工程抗体研究进展、人体自身肿瘤细胞杀伤活性与过继性免疫治疗、分子信号传导与肿瘤生物治疗.美国陈文典博士和日本田口铁男教授也在大会上分别报告了癌侵袭转移的分子机制和日本BRM研究现状及展望.本次会议讨论的学术内容包括细胞因子治疗、体细胞治疗、抗体导向治疗、特异主动免疫治疗、基因治疗以及中医中药的应用,反映了我国肿瘤生物治疗领域?
The 5th National Conference on Tumor Biotherapy co-organized by the Cancer Society of China Anticancer Association, the Cancer Immunology and Biotherapy Committee of the Chinese Society of Immunology and the Cancer Society of the Chinese Medical Association, September 21 to September 25, 1997 Japan was grandly held in Chengdu, Sichuan. This conference is the largest academic conference of tumor biological therapy so far, with representatives from more than 200 medical research institutions in 27 provinces, municipalities and autonomous regions in China and scholars and health professionals from Japan, the United States, and Taiwan. A total of more than 300 leaders of the Ministry attended the meeting. Domestic well-known experts and scholars Zhang Youhui, Dong Zhiwei, Gu Jianren, Qian Zhenchao, Cao Xuetao, Tang Jian, Tian Zhigang, Ma Dalong, Wang Hao, Wei Yuquan, Shou Chengchao, etc. made inviting reports on the Daquan. The main topics include: A new approach to the treatment of tumor lung metastases, the onset trend of cancer in China and the significance of biotechnology in its prevention and treatment, yesterday and tomorrow of gene therapy, the progress of tumor-specific immunotherapy, and antigen presentation Cell and tumor biotherapy, non-viral-mediated gene transfer, NK cell and immunoregulatory functions Advances in Cytokine Research, Advances in Genetically Engineered Antibodies, Human Tumor Cell Killing Activity and Adoptive Immunotherapy, Molecular Signal Transduction, and Tumor Biotherapy. Dr. Chen Wendian from the United States and Prof. Taguchi from Japan also reported cancer invasions. The molecular mechanism of metastasis and the status quo and prospects of BRM research in Japan. The academic contents discussed at this conference include cytokine therapy, somatic cell therapy, antibody-directed therapy, specific active immunotherapy, gene therapy, and application of traditional Chinese medicine, reflecting the Chinese tumor Treatment area?